Is Suprefort FDA approved?
No. This profile records Suprefort as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE BLOOD SUGAR BALANCER
A-1 Pancreatic Bioregulator Peptide
Suprefort is a pancreatic-derived bioregulator peptide that supports beta-cell health and insulin production. It works by modulating gene expression in pancreatic islet cells, enhancing their regeneration, and reducing inflammation. Similar to Pancragen, it's useful for metabolic syndrome, pre-diabetes, and maintaining healthy blood sugar with aging.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Suprefort as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 2 mg daily (oral or subcutaneous).
Schedule: daily. Cycle: 10-30 days on, repeat every 4-6 months. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Promotes insulin gene expression and PDX1
Supports beta-cell proliferation and survival
Reduces pancreatic inflammation via NF-κB
Enhances digestive enzyme secretion
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.